GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biogaia BIOG B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

124.30

+1.80%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 1.54bn

FY2016FY2025

Net income

SEK 332.8m

FY2016FY2025

Free cash flow

SEK 303.0m

FY2016FY2025

Shareholders' equity

SEK 1.31bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 1.54bnSEK 1.42bnSEK 1.30bnSEK 1.10bnSEK 785.1mSEK 747.1mSEK 768.3mSEK 741.9mSEK 615.0mSEK 534.7m
Gross profitSEK 1.13bnSEK 1.03bnSEK 950.2mSEK 801.9mSEK 583.0mSEK 546.9mSEK 564.0mSEK 555.9mSEK 463.3mSEK 387.8m
Research and developmentSEK 115.7mSEK 157.1mSEK 106.8mSEK 106.8mSEK 105.5mSEK 104.7mSEK 105.1mSEK 99.7mSEK 75.7mSEK 63.8m
Operating incomeSEK 412.5mSEK 423.4mSEK 443.1mSEK 361.5mSEK 253.7mSEK 228.2mSEK 242.5mSEK 277.4mSEK 233.8mSEK 199.4m
Net incomeSEK 332.8mSEK 351.4mSEK 365.4mSEK 373.8mSEK 196.3mSEK 179.7mSEK 187.3mSEK 214.9mSEK 180.6mSEK 227.6m
Diluted earnings per share3.293.473.623.701.951.892.162.482.082.62

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 1.60bnSEK 2.03bnSEK 2.33bnSEK 2.21bnSEK 2.13bnSEK 1.91bnSEK 665.9mSEK 660.0mSEK 576.1mSEK 489.0m
Cash and short-term investmentsSEK 801.3mSEK 1.22bnSEK 1.54bnSEK 1.49bnSEK 1.48bnSEK 1.47bnSEK 218.8mSEK 289.8mSEK 310.9mSEK 243.1m
Total liabilitiesSEK 283.6mSEK 310.1mSEK 305.5mSEK 241.5mSEK 250.7mSEK 167.0mSEK 158.0mSEK 151.9mSEK 112.2mSEK 73.8m
DebtSEK 6.9mSEK 7.1mSEK 8.8mSEK 16.0mSEK 10.4mSEK 29.6mSEK 26.2m−SEK 24.9m−SEK 36.6m−SEK 21.8m
Shareholders' equitySEK 1.31bnSEK 1.72bnSEK 2.03bnSEK 1.97bnSEK 1.88bnSEK 1.75bnSEK 507.9mSEK 505.0mSEK 463.9mSEK 415.2m
Shares outstanding101m101m101m101m101m95m87m87m87m87m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 306.6mSEK 373.2mSEK 426.0mSEK 318.9mSEK 221.9mSEK 221.3mSEK 147.9mSEK 183.1mSEK 222.6mSEK 147.9m
Capital spending−SEK 3.6m−SEK 14.2m−SEK 48.7m−SEK 17.9m−SEK 6.4m−SEK 16.1m−SEK 39.0m−SEK 13.5m−SEK 26.6m−SEK 5.6m
Free cash flowSEK 303.0mSEK 359.1mSEK 377.3mSEK 301.0mSEK 215.5mSEK 205.2mSEK 108.8mSEK 169.7mSEK 196.0mSEK 142.3m
Dividends paid−SEK 698.0m−SEK 696.8m−SEK 292.8m−SEK 301.3m−SEK 68.9m−SEK 65.0m−SEK 173.4m−SEK 156.0m−SEK 130.0m−SEK 124.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 440.9mSEK 372.6mSEK 440.6mSEK 326.6mSEK 404.7mSEK 366.3mSEK 364.8mSEK 304.0m
Gross profitSEK 320.9mSEK 266.8mSEK 323.8mSEK 242.5mSEK 293.9mSEK 268.4mSEK 258.5mSEK 222.3m
Operating incomeSEK 125.2mSEK 101.2mSEK 121.0mSEK 90.0mSEK 108.3mSEK 97.1mSEK 103.4mSEK 41.4m
Net incomeSEK 103.2mSEK 79.4mSEK 98.8mSEK 65.9mSEK 87.9mSEK 80.2mSEK 81.9mSEK 36.6m
Diluted earnings per share1.020.780.980.650.870.790.810.36
Cash from operationsSEK 50.0mSEK 70.0mSEK 83.0mSEK 110.0mSEK 77.0mSEK 35.0mSEK 103.0mSEK 100.0m
Capital spending−SEK 12.0m−SEK 1.0m—−SEK 1.0m−SEK 1.0m—−SEK 1.0m−SEK 2.0m
Free cash flowSEK 38.0mSEK 69.0m—SEK 109.0mSEK 76.0m—SEK 102.0mSEK 98.0m
Total assetsSEK 1.34bnSEK 1.69bnSEK 1.60bnSEK 1.49bnSEK 1.43bnSEK 2.03bnSEK 2.03bnSEK 1.90bn
Cash and short-term investmentsSEK 446.3mSEK 871.8mSEK 801.3mSEK 728.1mSEK 622.3mSEK 1.25bnSEK 1.22bnSEK 1.11bn
Debt——SEK 6.9m———SEK 7.1m—
Shareholders' equitySEK 1.10bnSEK 1.40bnSEK 1.31bnSEK 1.22bnSEK 1.15bnSEK 1.78bnSEK 1.72bnSEK 1.62bn

Financial ratios

Data as of 5 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin73.4%72.4%73.3%72.6%74.3%73.2%
Operating margin26.8%29.8%34.2%32.7%32.3%30.5%
Net margin21.6%24.7%28.2%33.9%25.0%24.1%
Return on equity25.3%20.4%18.0%19.0%10.5%10.3%
Return on assets20.8%17.3%15.6%16.9%9.2%9.4%
Free cash flow yield2.6%3.3%4.0%2.9%1.9%2.1%
Revenue growth8.1%9.7%17.4%40.6%5.1%-2.8%
Earnings growth-5.3%-3.8%-2.3%90.4%9.2%-4.1%
Current ratio6.12x7.81x9.46x10.89x13.80x12.51x
Debt to equity0.01x0.00x0.00x0.01x0.01x0.01x
Equity ratio82.3%84.8%87.0%89.1%88.2%91.3%
Interest coverage48.84x28.37x547.72x67.11x224.15x316.00x
R&D as a share of sales7.5%11.0%8.2%9.7%13.4%14.0%
Buybacks as a share of market value0.0%-0.2%0.0%-0.3%-5.8%-9.9%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.7%15.5%12.3%
Operating income4.5%12.6%10.5%
Net income-3.8%13.1%10.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin72.9%73.0%73.1%73.2%
Operating margin28.2%30.6%30.8%32.2%
Net margin23.1%26.5%26.1%27.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings32.232.228.022.653.256.939.325.631.322.9
Price to sales7.08.07.97.613.313.79.67.49.29.7

Dividends and splits

Per share, in the currency the company pays

Paid for 17 years. Last went ex-dividend on 8 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year4.006.906.902.902.9840.6820.752.00
  • 5-for-1 split · 18 May 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.